Stay updated on Margetuximab in Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Margetuximab in Advanced Breast Cancer Clinical Trial page.
Latest updates to the Margetuximab in Advanced Breast Cancer Clinical Trial page
- Check2 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.3%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check38 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference3%
- Check46 days agoChange DetectedThe website has removed detailed information about a completed Phase 2 study of the monoclonal antibody MGAH22 (Margetuximab) for advanced breast cancer, which evaluated its effectiveness in patients with specific HER2 expression levels.SummaryDifference78%
- Check53 days agoChange DetectedThe website has added new features for user interaction while removing extensive details about participant groups, interventions, and various data fields available for download.SummaryDifference4%
- Check67 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference5%
Stay in the know with updates to Margetuximab in Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Margetuximab in Advanced Breast Cancer Clinical Trial page.